Literature DB >> 32999887

Assessment of Occult Pulmonary Involvement in Ulcerative Colitis.

Sudhir J Gupta1, Vineet L Gupta1, Harit G Kothari1, Amol R Samarth1, Nitin R Gaikwad1, Sahil M Parmar1.   

Abstract

INTRODUCTION: Nearly 50% of patients with inflammatory bowel disease (IBD) experience at least one extraintestinal manifestation. Bronchopulmonary involvement is rare in IBD. Pulmonary function test (PFT) abnormality in cases of ulcerative colitis (UC) has been reported to be 17-55%. Occult pulmonary disease may be diagnosed using variables of the PFT. Hence, we aim to evaluate the frequency and type of pulmonary dysfunction in patients with UC in remission.
METHODS: Eighty-three patients of UC in remission and 48 controls underwent the PFT including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), Tiffeneau value (FEV1/FVC), and midexpiratory flow (MEF 25-75%) rate with a spirometer. The patients were divided based on the age of onset of UC into A1 (<16 years), A2 (16-40 years), and A3 (>40 years) and based on the extent of disease into E1 (proctitis), E2 (left-sided colitis), and E3 (extensive colitis).
RESULTS: Patients with UC had significantly abnormal PFT compared with controls (51 [61.5%] vss. 8 [16.67%]; p = 0.000). Patients with UC commonly had a restrictive pattern (33 [64.47%]) of PFT followed by small airway disease (11 [21.56%]) and obstructive pattern (7 [13.72%]). Pulmonary involvement in cases of UC was more in E3 followed by E2 and E1. Pulmonary involvement was more in the late age of onset of disease. BMI was positively and significantly correlated with FEV1 and FVC. Hemoglobin had a positive and significant correlation with FEV1 while a negative correlation with FEV1/FVC and MEF 25-75%. All predictors except for age were found to contribute in higher risk (OR > 1) for PFT abnormality.
CONCLUSION: Patients with UC have chronic pulmonary inflammation leading to different patterns of lung involvement in the form of restrictive, obstructive airway, and small airway disease. Patients with UC commonly have a restrictive pattern of pulmonary involvement. Impairment of the PFT is related to the disease extent and the age of onset of disease. Assessment of the PFT using a spirometer is a noninvasive, simple, cost-effective, and reliable method for early detection of occult pulmonary involvement in patients of UC.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Extraintestinal manifestation; Occult pulmonary disease; Pulmonary involvement; Restrictive pattern; Ulcerative colitis

Year:  2020        PMID: 32999887      PMCID: PMC7506263          DOI: 10.1159/000508772

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  42 in total

Review 1.  The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology.

Authors:  Ossama A Hatoum; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2005-03       Impact factor: 5.325

2.  Pulmonary function in inflammatory bowel disease.

Authors:  N M Johnson; A S Mee; D P Jewell; S W Clarke
Journal:  Digestion       Date:  1978       Impact factor: 3.216

3.  Evidence of lymphocyte alveolitis in Crohn's disease.

Authors:  B Wallaert; J F Colombel; A B Tonnel; P Bonniere; A Cortot; J C Paris; C Voisin
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

4.  Pulmonary function abnormalities in patients with ulcerative colitis.

Authors:  P G Godet; R Cowie; R C Woodman; L R Sutherland
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

5.  Pulmonary function abnormalities in patients with inflammatory bowel disease.

Authors:  R V Heatley; P Thomas; E J Prokipchuk; J Gauldie; D J Sieniewicz; J Bienenstock
Journal:  Q J Med       Date:  1982

6.  Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.

Authors:  K R Herrlinger; M K Noftz; K Dalhoff; D Ludwig; E F Stange; K Fellermann
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

7.  Pulmonary involvement in inflammatory bowel disease.

Authors:  Aydin Yilmaz; Nilgün Yilmaz Demirci; Derya Hoşgün; Enver Uner; Yurdanur Erdoğan; Atila Gökçek; Atalay Cağlar
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

8.  Pulmonary and hematological alterations in idiopathic ulcerative colitis.

Authors:  Pradeepta Kumar Sethy; Usha Dutta; Ashutosh N Aggrawal; Reena Das; Madhu Gulati; Saroj Kant Sinha; Kartar Singh
Journal:  Indian J Gastroenterol       Date:  2003 Sep-Oct

Review 9.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

Review 10.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Horace Williams; David Walker; Timothy R Orchard
Journal:  Curr Gastroenterol Rep       Date:  2008-12
View more
  2 in total

Review 1.  Pathophysiological Concepts and Management of Pulmonary Manifestation of Pediatric Inflammatory Bowel Disease.

Authors:  Florian Schmid; Cho-Ming Chao; Jan Däbritz
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Gegen Qinlian Decoction Alleviates Experimental Colitis and Concurrent Lung Inflammation by Inhibiting the Recruitment of Inflammatory Myeloid Cells and Restoring Microbial Balance.

Authors:  Yalan Li; Na Li; Jiajing Liu; Tieshan Wang; Ruijuan Dong; Dongyu Ge; Guiying Peng
Journal:  J Inflamm Res       Date:  2022-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.